Brendel Financial Advisors LLC Bristol Myers Squibb CO Transaction History
Brendel Financial Advisors LLC
- $165 Million
- Q4 2024
A detailed history of Brendel Financial Advisors LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Brendel Financial Advisors LLC holds 4,772 shares of BMY stock, worth $266,420. This represents 0.16% of its overall portfolio holdings.
Number of Shares
4,772
Previous 4,809
0.77%
Holding current value
$266,420
Previous $249,000
8.43%
% of portfolio
0.16%
Previous 0.14%
Shares
13 transactions
Others Institutions Holding BMY
# of Institutions
2,751Shares Held
1.57BCall Options Held
28MPut Options Held
28.7M-
Vanguard Group Inc Valley Forge, PA190MShares$10.6 Billion0.19% of portfolio
-
Black Rock Inc. New York, NY159MShares$8.86 Billion0.15% of portfolio
-
Jpmorgan Chase & CO New York, NY96MShares$5.36 Billion0.44% of portfolio
-
State Street Corp Boston, MA95.1MShares$5.31 Billion0.22% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA60.3MShares$3.37 Billion0.65% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $119B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...